Latest revenue
$2.3M
as of 2026-03-31
Latest net income
$-152.7K
as of 2026-03-31
Net margin
-6.7%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $6.0M
- Enterprise value
- $6.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $5.51
- 52-wk low
- $1.75
- Beta
- —
- Shares out
- 2.8M
5-year trend
What this company does
Item 1. Business Overview Lifeloc Technologies, Inc., a Colorado corporation ("Lifeloc" or the "Company"), is a Colorado-based developer, manufacturer and marketer of portable hand-held and fixed station breathalyzers and related accessories, supplies and education. We design, produce and sell fuel-cell based breath alcohol testing equipment. We compete in all major segments of the portable breath alcohol testing instrument market, including law enforcement, workplace, corrections, original equipment manufacturing ("OEM") and consumer markets. In addition, we offer a line of supplies, accessories, services, and training to support customers' alcohol testing programs. We sell globally…
AI summary unavailable — showing raw filing excerpt
Generated from LCTC's filing dated 2026-03-27
Key risks
Item 1A. Risk Factors You should carefully consider the risk factors described below. If any of the following risk factors actually occur, our business, prospects, financial condition or results of operations would likely suffer. In such case, the trading price of our common stock could fall, resulting in the loss of all or part of your investment. You should look at all these risk factors in total. Some risk factors may stand on their own. Some risk factors may affect (or be affected by) other risk factors. You should not assume we have identified these connections. You should not assume that we will always update these and future risk factors in a timely manner. Except as required under…
AI summary unavailable — showing raw filing excerpt
Generated from LCTC's filing dated 2026-03-27
Profitability
Gross margin
40.3%
0.0%Operating margin
-13.6%
17.4%Net margin
-27.4%
121.9%Return on equity
-60.2%
255.9%Return on assets
-36.9%
206.1%Leverage
Debt / equity
0.63×
56.8%Long-term debt / equity
0.26×
43.5%Debt / assets
38.6%
34.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $2.3M | +0.7% | $-152.7K | +47.8% | -6.7% |
Q4 2025 2025-12-31 | $2.3M | +19.0% | $-1.5M | -386.1% | -66.9% |
Q3 2025 2025-09-30 | $2.3M | +8.2% | $-263.4K | -66.4% | -11.7% |
Q2 2025 2025-06-30 | $2.2M | -7.0% | $-393.6K | -32.1% | -17.7% |
Q1 2025 2025-03-31 | $2.3M | +5.7% | $-292.7K | -3.1% | -12.9% |
Q4 2024 2024-12-31 | $1.9M | — | $-312.8K | — | -16.4% |
Q3 2024 2024-09-30 | $2.1M | -22.6% | $-158.3K | -244.5% | -7.6% |
Q2 2024 2024-06-30 | $2.4M | +4.7% | $-298.0K | -22059.3% | -12.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Laboratory Analytical Instruments · SIC 3826
Your notes
Keep private notes on LCTC — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for LCTC in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns LCTC
No institutional holdings on file for LCTC yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once LCTC's latest filing finishes processing.